tiprankstipranks
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market

ZyVersa Therapeutics (ZVSA) Financial Statements

Compare
171 Followers

ZyVersa Therapeutics Financial Overview

ZyVersa Therapeutics's market cap is currently $3.06M. The company's EPS TTM is $-43.19; its P/E ratio is ―; ZyVersa Therapeutics is scheduled to report earnings on April 7, 2025, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -10.40K$ -10.40K$ -10.40K$ -10.40K
Operating Income$ -14.42M$ -13.01M$ -7.70M$ -11.83M
EBITDA$ -107.74M$ -11.67M$ -7.25M$ -12.16M
Net Income$ -98.30M$ -759.10M$ -8.91M$ -13.20M
Balance Sheet
Cash & Short-Term Investments$ 3.14M$ 5.90M$ 328.58K$ 174.67K
Total Assets$ 22.11M$ 118.51M$ 1.13M$ 685.57K
Total Debt$ 8.66K$ 108.76K$ 9.15M$ 3.82M
Net Debt$ -3.13M$ -5.79M$ 8.82M$ 3.64M
Total Liabilities$ 11.04M$ 18.51M$ 13.63M$ 9.24M
Stockholders' Equity$ 11.07M$ 99.99M$ -12.50M$ -8.56M
Cash Flow
Free Cash Flow$ -8.72M$ -1.49M$ -5.08M$ -5.11M
Operating Cash Flow$ -8.72M$ -1.49M$ -5.08M$ -5.11M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 5.96M-$ 5.23M$ 4.56M
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History

ZyVersa Therapeutics Debt to Assets

ZyVersa Therapeutics Cash Flow

ZyVersa Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis